{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T02:47:27Z","timestamp":1768445247383,"version":"3.49.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2009,9,12]],"date-time":"2009-09-12T00:00:00Z","timestamp":1252713600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2009,10]]},"DOI":"10.1007\/s12185-009-0418-y","type":"journal-article","created":{"date-parts":[[2009,9,11]],"date-time":"2009-09-11T01:04:55Z","timestamp":1252631095000},"page":"392-396","source":"Crossref","is-referenced-by-count":30,"title":["HHV8-positive, HIV-negative multicentric Castleman\u2019s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma"],"prefix":"10.1007","volume":"90","author":[{"given":"Paolo","family":"Nicoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ubaldo","family":"Familiari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Bosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tiziano","family":"Allice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mete","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Morotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniela","family":"Cilloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Saglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Guerrasio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,9,12]]},"reference":[{"key":"418_CR1","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1182\/blood.V86.4.1276.bloodjournal8641276","volume":"86","author":"J Soulier","year":"1995","unstructured":"Soulier J, Grollet L, Oksenhendler E, Cacoub P, Cazals-Hatem D, Babinet P, et al. Kaposi\u2019s sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman\u2019s disease. Blood. 1995;86:1276\u201380.","journal-title":"Blood"},{"issue":"6","key":"418_CR2","first-page":"1517","volume":"151","author":"C Parravicini","year":"1997","unstructured":"Parravicini C, Corbellino M, Paulli M, Magrini U, Lazzarino M, Moore PS, et al. Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman\u2019s disease. Am J Pathol. 1997;151(6):1517\u201322.","journal-title":"Am J Pathol"},{"key":"418_CR3","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1097\/MOH.0b013e328186ffab","volume":"14","author":"A Dham","year":"2007","unstructured":"Dham A, Peterson BA. Castleman disease. Curr Opin Hematol. 2007;14:354\u20139.","journal-title":"Curr Opin Hematol"},{"issue":"8","key":"418_CR4","doi-asserted-by":"publisher","first-page":"2627","DOI":"10.1182\/blood-2004-12-4602","volume":"106","author":"N Nishimoto","year":"2005","unstructured":"Nishimoto N, Kanakura Y, Aozasa K, Johkoh T, Nakamura M, Nakano S, et al. Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood. 2005;106(8):2627\u201332.","journal-title":"Blood"},{"key":"418_CR5","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1182\/blood.V97.7.2130","volume":"97","author":"MQ Du","year":"2001","unstructured":"Du MQ, Liu H, Diss TC, Ye H, Hamoudi RA, Dupin N, et al. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood. 2001;97:2130\u20136.","journal-title":"Blood"},{"key":"418_CR6","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1182\/blood.V95.4.1406.004k26_1406_1412","volume":"95","author":"N Dupin","year":"2000","unstructured":"Dupin N, Diss TL, Kellam P, Tulliez M, Du MQ, Sicard D, et al. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood. 2000;95:1406\u201312.","journal-title":"Blood"},{"key":"418_CR7","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/00002030-199601000-00009","volume":"10","author":"E Oksenhendler","year":"1996","unstructured":"Oksenhendler E, Duarte M, Soulier J, Cacoub P, Welker Y, Cadranel J, et al. Multicentric Castleman\u2019s disease in HIV infection: a clinical and pathological study of 20 patients. AIDS. 1996;10:61\u20137.","journal-title":"AIDS"},{"issue":"8","key":"418_CR8","doi-asserted-by":"publisher","first-page":"2786","DOI":"10.1182\/blood-2003-03-0951","volume":"102","author":"AG Marcelin","year":"2003","unstructured":"Marcelin AG, Aaron L, Mateus C, Gyan E, Gorin I, Viard JP, et al. Rituximab therapy for HIV-associated Castleman disease. Blood. 2003;102(8):2786\u20138.","journal-title":"Blood"},{"issue":"12","key":"418_CR9","doi-asserted-by":"publisher","first-page":"836","DOI":"10.7326\/0003-4819-147-12-200712180-00003","volume":"147","author":"M Bower","year":"2007","unstructured":"Bower M, Powles T, Williams S, Davis TN, Atkins M, Montoto S, et al. Brief communication: rituximab in HIV-associated multicentric Castleman disease. Ann Intern Med. 2007;147(12):836\u20139.","journal-title":"Ann Intern Med"},{"issue":"1","key":"418_CR10","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1097\/COH.0b013e328319bca9","volume":"4","author":"E Oksenhendler","year":"2009","unstructured":"Oksenhendler E. HIV-associated multicentric Castleman disease. Curr Opin HIV AIDS. 2009;4(1):16\u201321.","journal-title":"Curr Opin HIV AIDS"},{"key":"418_CR11","doi-asserted-by":"publisher","first-page":"3350","DOI":"10.1200\/JCO.2007.10.6732","volume":"25","author":"L Gerard","year":"2007","unstructured":"Gerard L, Berezne A, Galicier L, Meignin V, Obadia M, De Castro N, et al. Prospective study of rituximab in chemotherapy-dependent human immunodeficiency virus associated multicentric Castleman\u2019s disease: ANRS 117 Castlema B Trial. J Clin Oncol. 2007;25:3350.","journal-title":"J Clin Oncol"},{"key":"418_CR12","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/1097-0142(197203)29:3<670::AID-CNCR2820290321>3.0.CO;2-#","volume":"29","author":"AR Keller","year":"1972","unstructured":"Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer. 1972;29:670\u201383.","journal-title":"Cancer"},{"issue":"3","key":"418_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1034\/j.1600-0609.2003.00038.x","volume":"70","author":"M Marietta","year":"2003","unstructured":"Marietta M, Pozzi S, Luppi M, Bertesi M, Cappi C, Morselli M, et al. Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman\u2019s disease: a case report. Eur J Haematol. 2003;70(3):181\u20132.","journal-title":"Eur J Haematol"},{"key":"418_CR14","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1007\/s00277-003-0718-x","volume":"82","author":"D Gholam","year":"2003","unstructured":"Gholam D, Vantelon JM, Al-Jijakli A, Bourhis JH. A case of multicentric Castleman\u2019s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol. 2003;82:766\u20138.","journal-title":"Ann Hematol"},{"issue":"6","key":"418_CR15","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0001-7310(06)73425-1","volume":"97","author":"MA Pastor","year":"2006","unstructured":"Pastor MA, Vasco B, Mosquera JM, Deben G, Bautista P, Requena L. Two HHV8-related illnesses in a HIV-negative patient: Kaposi\u2019s sarcoma and multicentric Castleman\u2019s disease. Response to treatment with rituximab and CHOP. Actas Dermosifiliogr. 2006;97(6):385\u201390.","journal-title":"Actas Dermosifiliogr"},{"issue":"7","key":"418_CR16","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1007\/s12094-006-0056-2","volume":"8","author":"JM Cervera Grau","year":"2006","unstructured":"Cervera Grau JM, Galiana Esquerdo G, Llorca Ferrandiz C, Briceno Garcia H, Diaz Castellano M, Ferriz Moreno P. Complete remission in a pancytopenic HIV negative, HHV-8 positive patient with multicentric Castleman\u2019s disease induced with anti-CD20. Clin Transl Oncol. 2006;8(7):540\u20131.","journal-title":"Clin Transl Oncol"},{"issue":"11","key":"418_CR17","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1080\/10428190802389835","volume":"49","author":"A Fragasso","year":"2008","unstructured":"Fragasso A, Mannarella C, Ciancio A, Calvario A, Scarasciulli ML. Complete remission and virologic response to combined chemoimmunotherapy (R-CVP) followed by rituximab maintenance in HIV-negative, HHV-8 positive patient with multicentric Castleman disease\u2019. Leuk Lymphoma. 2008;49(11):2224\u20136.","journal-title":"Leuk Lymphoma"},{"key":"418_CR18","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/j.humpath.2008.02.010","volume":"39","author":"C Laurent","year":"2008","unstructured":"Laurent C, Meggetto F, Brousset P. Human herpesvirus 8 infections in patients with immunodeficiencies. Hum Pathol. 2008;39:983\u201393.","journal-title":"Hum Pathol"},{"key":"418_CR19","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/S0002-9440(10)64940-1","volume":"156","author":"C Parravicini","year":"2000","unstructured":"Parravicini C, Chandran B, Corbellino M, Berti E, Paulli M, Moore PS, et al. Differential viral protein expression in Kaposi\u2019s sarcoma-associated herpesvirus-infected diseases: Kaposi\u2019s sarcoma, primary effusion lymphoma, and multicentric Castleman\u2019s disease. Am J Pathol. 2000;156:743\u20139.","journal-title":"Am J Pathol"},{"key":"418_CR20","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.1182\/blood-2007-03-080648","volume":"111","author":"A Guihot","year":"2008","unstructured":"Guihot A, Oksenhendler E, Galicier L, Marcelin AG, Papagno L, Bedin AS, et al. Multicentric Castleman disease is associated with polyfunctional effector memory. Blood. 2008;111:1387\u201395.","journal-title":"Blood"},{"issue":"2","key":"418_CR21","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1111\/j.1600-0609.2005.00570.x","volume":"76","author":"M Ide","year":"2006","unstructured":"Ide M, Kawachi Y, Izumi Y, Kasagi K, Ogino T. Long-term remission in HIV-negative patients with multicentric Castleman\u2019s disease using rituximab. Eur J Haematol. 2006;76(2):119\u201323.","journal-title":"Eur J Haematol"},{"key":"418_CR22","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/ajh.20283","volume":"78","author":"EM Ocio","year":"2005","unstructured":"Ocio EM, Sanchez-Guijo FM, Diez-Campelo M, Castilla C, Blanco OJ, Caballero D, et al. Efficacy of rituximab in an aggressive form of multicentric Castleman disease associated with immune phenomena. Am J Hematol. 2005;78:302\u20135.","journal-title":"Am J Hematol"},{"issue":"5","key":"418_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1111\/j.1600-0609.2007.00952.x","volume":"79","author":"L Falchi","year":"2007","unstructured":"Falchi L, Capello D, Palumbo B, Rauco A, Emili R, Cianciulli M, et al. A case of nodular sclerosis Hodgkin\u2019s lymphoma repeatedly relapsing in the context of composite plasma cell-hyaline vascular Castleman\u2019s disease: successful response to rituximab and radiotherapy. Eur J Haematol. 2007;79(5):455\u201361.","journal-title":"Eur J Haematol"},{"issue":"10","key":"418_CR24","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1440-1827.2006.02017.x","volume":"56","author":"Y Abe","year":"2006","unstructured":"Abe Y, Matsubara D, Gatanaga H, Oka S, Kimura S, Sasao Y, et al. Distinct expression of Kaposi\u2019s sarcoma-associated herpesvirus-encoded protein in Kaposi\u2019s sarcoma and multicentric Castleman\u2019s disease. Pathol Int. 2006;56(10):617\u201324.","journal-title":"Pathol Int"},{"key":"418_CR25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1182\/blood.V95.1.56","volume":"95","author":"N Nishimoto","year":"2000","unstructured":"Nishimoto N, Sasai M, Shima Y, Nakagawa M, Shirai T, Matsumoto T, et al. Improvement in Castleman\u2019s disease by humanized anti-interleukin-6 receptor antibody therapy. Blood. 2000;95:56\u201361.","journal-title":"Blood"},{"issue":"11","key":"418_CR26","doi-asserted-by":"publisher","first-page":"771","DOI":"10.2169\/internalmedicine.46.6262","volume":"46","author":"M Matsuyama","year":"2007","unstructured":"Matsuyama M, Suzuki T, Tsuboi T, Ito S, Mamura M, Goto D, et al. Anti-interleukin-6 receptor antibody (tocilizumab) treatment of multicentric Castleman\u2019s disease. Intern Med. 2007;46(11):771\u20134.","journal-title":"Intern Med"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12185-009-0418-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0418-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-009-0418-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T03:38:01Z","timestamp":1590118681000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12185-009-0418-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,12]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,10]]}},"alternative-id":["418"],"URL":"https:\/\/doi.org\/10.1007\/s12185-009-0418-y","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,12]]}}}